A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on COVID-19.
Follow us to keep up to date.
The Most Read Articles of 2021: COVID-19
01- Efficacy of the Sinopharm Vaccine Against COVID-19
Vaccines developed with two different inactivated strains of SARS-CoV-2 (Sinopharm) significantly reduced the risk of symptomatic cases of COVID-19 with an excellent safety profile. Its proven technology—already used against other virus (influenza, hepatitis, polio, rabies)—and the fact that they can be stored at 2-8 °C mean that they are easily (and cheaply) produced, stored, and administered.
Read more HERE
02- Diagnosis and Treatment of Vaccine-Induced Thrombosis
Cerebral venous sinus thrombosis is an extremely rare manifestation of cerebrovascular disease.
Read more HERE
03- Findings on Sputnik V Vaccine Against COVID-19
The Sputnik V vaccine was developed by Gamaleya NRCEM. Similarly to the Oxford-AstraZeneca vaccine, it is based on a viral vector, and its findings were published in Lancet.
Read more HERE
04- N95 and Surgical Face Mask Sterilization Is Feasible
This study shows re-sterilization of N95 and KN95 surgical face masks is indeed feasible, though not all techniques will render the same results and not all protection elements will keep filtration capacity.
Read more HERE
05- Thrombocytopenia and Thrombosis May Be Linked to AstraZeneca Vaccine, Analysis Reports
This is one of the first papers documenting rare thrombotic effects related to the ChAdOx1 nCoV-19 vaccine in Austria and Germany. These effects may be a type of thrombocytopenia after inoculation with the vaccine developed by Oxford University and AstraZeneca.
Read more HERE
06- Major Cause of Myocardial Injury by COVID-19
The most common cause of myocardial necrosis in patient undergoing COVID-19 infection is microthrombi. These microthrombi resulted quite different in composition vs. thrombi obtained from COVID-19 negative patients and thrombi obtained from infected patients with ACS.
Read more HERE
07- Efficacy of AstraZeneca’s Vaccine against COVID-19
This study, published in the Lancet, looks into the vaccine resulting from the collaboration of the Oxford University and AstraZeneca, among others.
Read more HERE
08- Myocarditis and Messenger RNA COVID-19 Vaccine: What Is the Risk?
European and American agencies (such as the Centers for Disease Control [CDC]) have begun evaluating reports on myocarditis in individuals who received one of the COVID-19 vaccines based on messenger RNA technology (Pfizer/BioNTech and Moderna).
Read more HERE
09- New Cardiac Failure Diagnoses after COVID-19 Infection
This is the largest study on new signs and symptoms of cardiac failure in patients after COVID-19. Even though low in prevalence, its occurrence in healthy patients with no prior risk factors is worrying.
Read more HERE
10- COVID-19 Risk in Vaccinated Healthcare Workers
Vaccinated healthcare workers have a risk of being infected with SARS-CoV-2 of about 1%, a rate that is much higher than that reported in clinical studies.
Read more HERE
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology
